FDA approves first cervical cancer screening device that can be used at home, company says

FDA approves cervical cancer at-home testing

The FDA approved its first-ever at-home test for cervical cancer called Teal Wand that detects HPV, which is responsible for nearly all cervical cancer.

New blood test shows superior sensitivity in detecting HPV-associated head and neck cancers

Head and neck cancer researchers are reporting the development and testing of HPV-DeepSeek, a novel liquid biopsy assay. In their new study, HPV-DeepSeek achieved 99% sensitivty and specifity for diagnosing HPV-associated head and neck cancers, outperforming standard of care methods. HPV causes about 70% of oropharyngeal cancers in the U.S., which are increasing in incidence faster than other head and neck cancers.

Teal posts data on newly approved at-home cancer screening device

Self-collection correctly identified 95.2% of HPV samples that are associated with increased cancer risk.

Teal Health Announces Publication of SELF-CERV Study Results in JAMA Network Open Following FDA Approval of Teal Wand™ for At-Home HPV Screening

SAN FRANCISCO, May 19, 2025 /PRNewswire/ -- Following its recent FDA approval, Teal Health® announced the publication of its multi-center pivotal SELF-CERV study in JAMA Network Open. The study supported the recent U.S. Food and Drug Administration (FDA) approval of…

An at-home cervical cancer screening device was OK‘d by the FDA

The Teal Wand, an at-home HPV testing device that could replace a Pap smear, could broaden access to cervical cancer screening.

FDA Approves At-Home Cervical Cancer Test with Promising Impact - One Green Planet

A new FDA-approved at-home test for cervical cancer could close screening gaps and help save lives with a simple, painless swab. The post FDA Approves At-Home Cervical Cancer Test with Promising Impact appeared first on One Green Planet.